cefetamet pivoxyl has been researched along with Sepsis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angehrn, P; Hohl, P; Then, RL | 1 |
1 other study(ies) available for cefetamet pivoxyl and Sepsis
Article | Year |
---|---|
In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.
Topics: Animals; Bacteria; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Ceftizoxime; Drug Resistance, Microbial; Enterobacteriaceae; Haemophilus influenzae; Hexosyltransferases; Humans; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Neisseria; Penicillin-Binding Proteins; Peptidyl Transferases; Rats; Sepsis; Streptococcus; Vibrio | 1989 |